Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.2 - $2.17 $349,200 - $631,470
291,000 New
291,000 $494,000
Q1 2022

May 17, 2022

BUY
$8.43 - $20.9 $438,360 - $1.09 Million
52,000 Added 94.37%
107,100 $975,000
Q4 2021

Feb 15, 2022

SELL
$19.26 - $30.08 $564,318 - $881,344
-29,300 Reduced 34.72%
55,100 $1.13 Million
Q3 2021

Nov 16, 2021

SELL
$24.86 - $35.02 $1.37 Million - $1.93 Million
-55,000 Reduced 39.45%
84,400 $2.16 Million
Q2 2021

Aug 16, 2021

SELL
$22.3 - $36.02 $537,430 - $868,082
-24,100 Reduced 14.74%
139,400 $4.88 Million
Q1 2021

May 18, 2021

BUY
$26.38 - $51.15 $1.21 Million - $2.34 Million
45,700 Added 38.79%
163,500 $5.45 Million
Q4 2020

Feb 17, 2021

BUY
$10.5 - $28.5 $1.24 Million - $3.36 Million
117,800 New
117,800 $3.06 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.